Physitek Devices SAS

Physitek Devices SAS specializes in designing and manufacturing handheld spectrometers and analysis solutions, focusing on portable XRF, NIR, and LIBS technologies for diverse industrial applications. Physitek Devices SAS, founded in 1982, is based in France and is engaged in the development of portable spectrometers. The company has undergone strategic changes to enhance its product offerings. It has successfully completed 4 deals, with the most recent deal occurring on September 12, 2023.

Physitek Group specializes in the design and manufacturing of handheld spectrometers and analysis solutions, with a strong focus on portable XRF, NIR, and LIBS technologies. The company's flagship products include the FEnX-T XRF tube spectrometer for alloy composition analysis, the FEnX2 for lead diagnostics in paints and dust, and the Niton XL5 Plus, a portable XRF spectrometer for elemental analysis. These devices are engineered to provide rapid and accurate measurements, addressing critical needs in sectors such as home inspection, safety and security, pharmaceuticals, and materials analysis. The company serves a diverse client base, including industries in Europe and beyond, particularly in markets such as environmental analysis, metallurgy, and food safety.

The user-friendly and portable nature of these solutions allows end users, including inspectors, laboratory personnel, and safety officers, to perform on-site assessments efficiently. In 2023, Physitek Devices SAS reported a revenue of USD 1. 63 mn and an EBITDA of USD -375,900. The revenue model revolves around direct sales of their specialized spectrometers and analysis solutions to B2B clients across various sectors, including laboratories, construction, and environmental analysis.

The transactions typically involve one-time purchases or service agreements for the deployment of their spectrometers, which are tailored to meet specific industry needs. Their product lineup, including notable offerings like the Niton DXL for precious metal analysis and the MicroNIR OnSite W for raw material identification, is positioned as essential tools for quality control and compliance in industrial processes. The company’s pricing strategy reflects the advanced capabilities of these instruments, focusing on providing value through enhanced productivity and risk identification in critical applications. In September 2023, Physitek Devices SAS was acquired by a consortium including UI Investissement, Rives Croissance, SOCADIF Capital Investissement, and BNP Paribas Développement.

This investment aims to support the company in expanding its geographical presence and scaling its range of proprietary products while reinforcing its CSR commitments. Future growth initiatives include the development of new products, with specific details on upcoming releases yet to be disclosed, and targeted expansion into new markets and regions.